Abstract Eyes absent (EYA) and Sine oculis (SO/SIX) proteins function as transcriptional activation complexes and play essential roles in organogenesis during embryonic development in regulating cell proliferation and survival and coordination of particular differentiation programs. Mutations of the Eya and So/Six genes cause profound developmental defects in organisms as diverse as flies, frogs, fish, mice, and humans. EYA proteins also possess an intrinsic phosphatase activity, which is essential for normal development. Here, we review crucial roles of EYA and SO/SIX in development and disease in mice and humans.
Introduction
The Eyes absent (Eya) and Sine oculis (So/Six) gene families were first identified in Drosophila as key coregulators for eye development and subsequently they were identified in a number of species ranging from worms, frogs, fish, birds, and to higher vertebrates [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Eya is also found in plants such as Arabidopsis and rice [14] and homologues of So/Six genes have been identified in sponges [15] . While So/Six genes encode transcription factors with direct DNA-binding capacity, Eya genes encode proteins that affect transcription indirectly by interacting with DNA-binding proteins such as SO/ SIX as well as other DNA-binding proteins. The key role of EYA-SO/SIX during development and disease was first revealed by loss-and gain-of-function studies in fruit flies. In Drosophila, eya functions in a molecular network with the fly Pax6 gene eyeless (ey), so and dachshund (dach) to regulate eye morphogenesis ( Fig. 1) [16]. The components of this network have been highly conserved during evolution with related genes in mammals regulating the development of multiple organ systems [17, 18] . When misexpressed, eya acts synergistically with so or dach to direct the formation of ectopic eyes [19, 20] . Genetic analyses indicate that eya is epistatic to so and both reside in a transcriptional network downstream of ey ( Fig. 1) [21, 22] .
While there appears to be only a single eya or so gene in fruit flies, at least four Eya (Eya1-4) and six So (Six1-6) genes are present in the mammalian genome [2, 9, [23] [24] [25] (Fig. 2) . EYA proteins are defined by the presence of a 271-273-amino acid conserved C-terminal domain, the Eya domain (ED). SO/SIX proteins are identified by the presence of two evolutionarily conserved domains, a 110-115-amino acid SO/SIX-specific domain (SD) and a 60-amino acid homeodomain (HD). Crucial functions during organogenesis have been described for several EYA and SO/SIX family members in a variety of organisms. Recent studies have provided exciting data suggesting that EYA and SO/SIX proteins have roles at several stages during organ development, including cell fate specification, proliferation, differentiation, and maintenance. In this review, we provide a general background to the EYA-SO/SIX complex and focus on the roles of EYA-SO/SIX in inner-ear and renal development and diseases.
EYA and SO/SIX family proteins and their functional domains
Eya gene products operate as both transcription cofactors and phosphatases. Transactivation assays identify the divergent N-terminal transcription activation domain in EYA proteins (Fig. 2) [26]. The conserved Eya domain not only interacts with other proteins but also possesses a catalytic motif belonging to the phosphatase subgroup of the haloacid dehalogenase (HAD) superfamily of enzymes [27] [28] [29] . Work from several groups has demonstrated that EYA protein has phosphatase capability in vitro either as a protein tyrosine phosphatase (PTP) when using recombinant Eya domain (the catalytic domain-containing region only) [27, 28] or as both protein tyrosine and serine-threonine phosphatase when using recombinant full-length EYA [29] . These findings suggest that EYA is likely to regulate the phosphorylation state of its transcriptional cofactors or itself to directly modify transcriptional output within a cell.
The physiologically relevant substrates remain largely unknown. In vitro studies have identified RNA polymerase II [29] and EYA itself [28] but neither has been validated in vivo. Recent studies have identified DNA damage-related histone H2AX as EYA's first in vivo relevant substrate [30, 31] . However, it is not understood whether the two functions depend on each other and how they operate during development in mammals. Future studies involving isolation of more binding partners and in vivo substrates of EYA will likely reveal the nature of how its functions as both transcriptional coactivator and phosphatase are interconnected and used throughout development.
The SO/SIX family represents a divergent group of the homeodomain (HD) superfamily of transcription factors and it contains the HD and the SO/SIX-specific domain (SD) involved in protein-protein interactions with EYA and other proteins ( Fig. 2) [20]. SO/SIX family members have been divided into three subfamilies (SIX1/2, SIX4/5, and SIX3/6) on the basis of Drosophila SO, which belongs to the same subfamily as vertebrate SIX1/2 (Fig. 2) . The SO/SIX HD binds to a TGATAC consensus sequence, differing from the classic TAAT core sequence because it lacks two highly conserved amino acid residues typical of most HDs [1, [32] [33] [34] . However, the HD of SIX3/6 can also bind to a common TAATGTC motif [35] . Depending on the context, SO/SIX proteins can act as either transcriptional activators [36, 37] or repressors [38] . When both EYA and SO/SIX are coexpressed, EYA-SO/SIX interactions lead to the formation of a bipartite transcription factor, with the homeodomain of SO/SIX providing the DNAbinding activity and the N-terminus of EYA providing Fig. 1 The EYA-SO/SIX regulatory network. a The transcriptional hierarchy among the key regulators in the fly eye discs. Feedback loops and protein-protein interactions (double-headed arrows) are indicated. b EYA and SIX form transcriptional activation complexes to control cell proliferation and survival, as well as to trigger particular differentiation programs. EYA-SIX also interact with other proteins (X), which may vary depending on distinct developmental and cellular contexts and modify the specificity of EYA-SIX function the transactivation potential, which leads to potent transcriptional activation-even under conditions in which SO/SIX alone acts as a repressor [36] [37] [38] [39] .
Factors that interact physically with EYA and SO/SIX proteins and regulate their transcriptional activity have been identified by yeast two-hybrid screens and immunoprecipitation. Recent findings have demonstrated that SOX2 physically interacts with EYA1 or SIX1 both in vitro and in vivo to synergize transcriptional output of EYA1-SIX1 during sensory cell development [39] and neurogenesis [40] in the inner ear. In addition to SOX2, components of the SWI/SNF chromatin-remodeling complex and the helix-loop-helix (bHLH) transcription factors NEUROG1 and NEUROD1 are found to be binding partners of EYA1 and SIX1 during inner-ear neurogenesis [40] . G protein subunits [41] [42] [43] and two novel EYA1-binding partners Sipl1 (Shank-interacting protein-like 1) and Rbck1 (RBCC protein interacting with PKC1) have been identified through yeast twohybrid screens [44] , while the T-box transcription factor TBX18 is found to physically interact with SIX1 protein both in vitro and in vivo [45] . However, how these protein-protein interactions modify transcriptional activation and repression activities remain to be elucidated. Below, specific functions of EYA-SO/SIX during development and disease will be discussed and common themes will be emphasized.
Nuclear and cytoplasmic roles of EYA
While the EYA-SO/SIX transactivation activity clearly represents a nuclear function, the phosphatase activity functions in either the nucleus or cytoplasm. The Drosophila EYA is primarily localized to the nucleus, both in cultured cells and in flies [46] [3, 18, 29, [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] . Mutants of Eya1 and Six1 exhibit a very similar spectrum of deficiencies reflecting their coexpression and synergistic interaction in different tissues. In humans, mutations in EYA1 or SIX1 cause branchio-otorenal (BOR) syndrome, an autosomal dominant disorder with incomplete penetrance and variable expressivity characterized by combinations of branchial, otic, and renal anomalies [3, 62, 68] . EYA1 or SIX1 mutations also account for some cases of branchio-oto (BO) syndrome, a second disorder lacking the renal defects observed in BOR syndrome [69] . Mutations of EYA1 were also detected in patients with congenital cataracts and ocular anterior segment anomalies [70] . In addition, a frameshift mutation of EYA1 has been linked to cardiofacial syndrome characterized by the combination of an asymmetric crying face and heart defect [71] . SIX1 mutations isolated from human patients have been characterized and are found to disrupt the ability of SIX1 to bind EYA1, or to bind DNA [62] . Four mutations in the SIX5 gene were also identified from BOR/ BO patients and these mutations are also found to affect EYA1-SIX5 interaction [68] . Similarly, EYA1 point mutations identified within the conserved Eya domain that cause a single amino acid substitution abolish EYA1-SIX interaction [48] . In addition, EYA1 mutants that are defective in their intrinsic phosphatase activity have been identified in BOR patients [72] . These data indicate that both EYA1's interaction with SIX1 and its phosphatase activity are crucial for normal development.
Many placodal-derived sensory structures in Eya1 or Six1 mutant mice are similarly affected [18, 57, 59, 60, 73]. There is much evidence that EYA1 or SIX1 is required not only for normal cell proliferation but also for survival. In the absence of either gene, progenitor cells fail to proliferate normally and undergo programmed cell death, thus leading to reduced size or absence of organ development [60, 73] . Recent studies have suggested that SIX1 may promote proliferation by interaction with cell cycle control genes such as CyclinA1, CyclinD1, and c-Myc [29, [74] [75] [76] , and that EYA1 may modulate apoptosis and survival decisions by dephosphorylating histone H2AX [30] .
New insights into the critical roles of EYA1-SIX1 in triggering particular developmental programs have recently been obtained. Recent results from loss-and gain-offunction analyses indicate that EYA1/SIX1 are likely to operate through different mechanisms to induce neuronal vs. sensory fate in the otic placode, with the former induced several days earlier than the latter during development [39] . During sensory hair cell development, EYA1-SIX1 is likely to physically interact and cooperate with SOX2 to synergistically activate the hair cell differentiation bHLH gene Atoh1 transcription via direct binding to the conserved Sox-and Six-binding sites in Atoh1 enhancers to specify hair cell fate [39] . In contrast, during neurogenesis, EYA1-SIX1 Six4 and Eya4 are also expressed early in placodes but their mutant mice do not show early placodal phenotype [77] . This may be due to the ability of SIX1 or EYA1 to functionally compensate for the loss of SIX4 or EYA4 to some degree, as suggested by enhanced placodal phenotypes observed in Six1/Six4 double-knockout mice [78, 79] . Mutations in the EYA4 gene cause late-onset autosomal dominant hearing loss at the DFNA10 locus [80] [81] [82] . This suggests that Eya4 plays an important role in inner-ear function. A recent study has shown that EYA4 and SIX3 interact both physically and functionally, and both genes have been reported to be mutated in some cases of holoprosencephaly [83] [84] [85] .
In addition to cranial sensory structures, the Eya and So/ Six genes are widely coexpressed in renal and urogenital ridge region, branchial arches and craniofacial region, dorsal root ganglion, skeletal muscles, heart, thymus, and parathyroid. Data from the analysis of Eya and So/Six mutants have demonstrated that these genes play important roles in the development of these organs/tissues as well as in tumorigenesis (Table 1) [52, [86] [87] [88] [89] . During skeletal muscle development, several direct targets for SO/SIX proteins, including Myogenin [34], aldolase A [90, 91] , and Myf5 [92] have also been identified. Below, the roles of EYA and SIX in renal development and diseases will be discussed.
EYA-SIX in renal development and diseases
Eya and So/Six family genes are known regulators of kidney development. In mammals, kidney development occurs in three stages that are all characterized by the mesenchyme-toepithelial transformation within the intermediate mesoderm.
The development of pronephros, the first kidney, is initiated at embryonic day 8 (E8) in mice when the nephric (Wolffian) duct (WD) forms from the intermediate mesoderm of the anterior region of the embryos [93, 94] . The mesonephros appears at E9.5 when the WD grows caudally and induces the adjacent nephrogenic mesoderm to aggregate and form mesonephric tubules. Both the pro-and mesonephros are transient organs and regress shortly after their formation. The development of metanephros or permanent kidney initiates at E10.5 when the ureteric bud (UB) appears as a thickening of the WD at its caudal end [95] . Its development involves several distinct processes: First, formation of the metanephric mesenchyme (MM) from intermediate mesoderm; second, induction and outgrowth of the UB; third, branching of the UB and differentiation of the mesenchyme into renal epithelial cells.
The MM appears as an aggregate of cells at the caudal end of the nephrogenic cord at around E10.5 in mice and the establishment of a functional MM is a central step in kidney organogenesis as this tissue has the specialized capability of inducing the growth and branching of the UB in its characteristic pattern [96] [97] [98] . The signals from the MM that regulate UB formation have been extensively reviewed [93, [99] [100] [101] . Among many of the signaling molecules, GDNF, which acts as a ligand that binds to the Ret receptor tyrosine kinase and the Gfrα1 coreceptor expressed in the WD, is a major inducer [96] [97] [98] [99] . Genetic studies have identified many other transcription factors, including HOX11, PAX2, OSR1, EYA1, WT1, SIX1, SIX4, and SALL1, which are important for stimulating and maintaining GDNF expression in the MM. Eya1 appears to be important for the expression of Gdnf, Six1, Six2, and Pax2, and it also genetically interacts with Six1 and Pax2 as kidney phenotype is enhanced in their compound mutants [17, 102] .
Prior to UB formation, the caudal WD swells to form a pseudostratified domain and previous data from Osr1 -/-mutants in which the WD fails to become pseudostratified suggests that an inductive signal from MM may act on the WD to induce pseudostratification [103] . However, GDNF does not appear to be required as the WD becomes pseudostratified in Ret -/-animals [104] . Deletion of Eya1 results in renal agenesis due to a complete absence of the MM (Fig. 3 ) [102] . The WD, pro-, and mesonephric tubules still form and the mutant WD is functionally competent for UB outgrowth as recombinant GDNF is able to induce UB formation from Eya1 -/-WD. However, the caudal WD is not pseudostratified and remains as a narrow epithelial tube in Eya1 -/-mutants [102] (J. Xu and P-X. Xu, unpublished), similar to that observed in Osr1 -/-mutants. Since Eya1 and Osr1 are coexpressed in the MM but not in the WD, the two genes might act together to regulate mesenchymal signals to induce pseudostratification. Further studies are required to define the nature of induction and what roles EYA1 plays to mediate pseudostratification.
In contrast to about 93 % of human BOR patients exhibiting hearing loss, only about 6 % of BOR patients reveal renal defects. This includes polycystic, hypoplastic, or totally absent kidneys and malformation of the collecting system, such as duplication or absence of the ureter, megaureter, blunted or distorted calyces, and extra or bifid pelvis [105] [106] [107] . These anomalies were observed in Eya1 heterozygous animals [57] . Since Eya1 is highly expressed in the undifferentiated cap mesenchyme and its expression is largely decreased in renal vesicles, it may play a critical role in regulating cell proliferation/renewal of the cap mesenchyme.
Among the nine members of the mammalian So/Six gene family, Six1, Six2, and Six4 are expressed in the mesenchyme, which overlaps with Eya1 [17, 108]. Deletion of Six1 or Six2 leads to abnormal kidney development [17, 57, 62, 108, 109] . Six4 appears to act synergistically with Six1 during normal development of the renal system, as the MM is not normally specified (J. Xu and P-X. Xu, unpublished) and Gdnf expression is not maintained in Six1;Six4 double mutants [108] . Six1 expression in the MM, which disappears after the initiation of UB branching, appears to mediate the expression of Six2 and Pax2. Inactivation of Six2 in mice leads to hypo-dysplastic kidney due to premature differentiation of metanephric mesenchymal progenitors [109, 110] . Mutations in the human SIX2 have been linked to renal 
embryos (d).
e Schematic drawing to show that upregulation of GREM1 by SIX1 in the MM is essential to locally restrict BMP4 signaling for the initiation of branching morphogenesis. In mice, the UB formation and outgrowth is induced by GDNF-RET signaling, which is initially expressed at normal levels in Six1 -/-embryos. During this inductive period, Six1 is expressed in the MM (green). Bmp4 (red) is expressed in the mesenchyme enveloping the WD and nascent UB. Grem1 transcripts are upregulated in the MM around the UB tip region, which may locally antagonize BMP4 to enable ampulla formation of the UB and its invasion into the MM. Gdnf expression is also upregulated during this period to stimulate ampulla formation and establish WNT11-GDNF signaling for branching of the ampulla. In Six1 -/-embryos, the UB outgrowth is normal but the tip cells fail to be induced for ampulla formation. Instead, the tip is wrapped up by Bmp4-expressing mesenchyme, which is the cellular source for ureteral mesenchyme [122] . By responding to the signaling in the Bmp4-positive mesenchyme, the tip is induced for ureter differentiation. Our results show that the balance between the levels of BMP4 activity in the Bmp4 + mesenchyme and GDNF production in the MM may also be critical for UB patterning, as excessive GDNF can restore branching as well as kidney formation in Six1 -/-kidney rudiments in culture and lowering BMP4 activity in vivo can rescue branching morphogenesis and nephron formation [115] (used with permission) hypodysplasia, which is characterized by maldevelopment of renal tissue and/or reduced kidney size [111] . Expression and genetic studies have shown that Eya1 and Six2 are coexpressed in the cap mesenchyme and that Eya1 is upstream of Six2 in the MM as Six2 expression is lost in Eya1 -/-mutants. Future studies will likely reveal that Eya1 and Six2 also act together to regulate cell proliferation/ renewal of the cap mesenchyme.
More recently, Six1 is found to be expressed in ureteral mesenchyme and it is essential for UB patterning by regulating BMP4-GREM1 interaction [45] . The balance between the levels of BMP4 activity in the mesenchyme surrounding the nascent UB tip and GDNF production in the MM is crucial for UB development into either ureter or collecting system. BMP4 is a mesenchymal regulator promoting ureter development and is expressed in the mesenchyme surrounding the WD [112, 113] . The BMP inhibitor GREM1 is initially expressed in the mesenchyme around the caudal WD and nascent UB and its expression gradually becomes restricted in the MM to negatively regulate BMP4 activity to induce UB branching (Fig. 4) . In Six1 -/-mutants, UB grows out normally and elongates to differentiate into ureter but fails to form collecting system caused by loss of Grem1 expression in the MM, which leads to retention of BMP4 levels [17, 29, 114, 115] (Fig. 4) . GREM1-soaked beads implanted into Six1 -/-kidney primordia in culture are sufficient to promote UB branching and removal of only one copy of the Bmp4 gene in Six1 -/-embryos restores UB patterning and kidney organogenesis [115] . These data indicate that lowering of mesenchymal BMP activity is likely to relieve repression of UB outgrowth and enable its invasion into the mesenchyme in response to GDNF signaling. Six1 might be specifically required for upregulating the expression of Grem1 in the MM to locally restrict BMP4 activity in the mesenchyme to initiate ampulla formation and branching morphogenesis during urinary tract morphogenesis (Fig. 4) . How SIX1 acts to regulate Grem1 expression and whether it interacts with EYA1 to trans-activate Grem1 remain to be characterized.
Although ureter forms in Six1 -/-mutants, the differentiation of smooth muscle cells is impaired [45, 114] . Genetic and in vitro analyses have shown that Six1 interacts with Tbx18 to regulate ureteral smooth muscle cell development [45] . However, the direct downstream targets of these two proteins remain to be identified.
Downstream targets of and transcriptional regulation by the EYA-SO/SIX complex
In the Drosophila eye, eya-so target genes include lozenge (lz), hedgehog (hh), ey, so, string, and atonal [116] [117] [118] . Only two of them, hh and lz, have been elegantly shown to be transcriptionally regulated by EYA-SO complex in combination with other signaling pathways [116, 118] . In vertebrates, while expression studies have reported that the expression of many genes were affected in Eya-or Six-null mice, SO/SIXbinding DNA elements were found in Na+/K+ ATPase α1 subunit, myogenin, Igfbp5, aldolase A, c-myc, Gdnf, cyclin A1, cyclin D1, Slc12a2, p27Kip1, muscle creatine kinase, ezrin, Six2, and Atoh1 [29, 32, 34, 38, 39, 75 
Conclusions and future directions
The studies summarized here have begun to elucidate the important functions that Eya and So/Six genes play during multiple stages of development. These multiple functions such as maintaining proliferative state of cells and triggering differentiation programs, suggest a diversity of activity at the cellular level. This diversity is reflected at the molecular level by complex modes of interaction with chromatin, multiple binding partners and sophisticated transcriptional activation and repression activities, as well as dephosphorylation and phosphorylation activities. However, details about how the EYA-SO/SIX network has been evolutionarily coopted and modified during distinct organ development, and their precise mode of action in mediating self-renewal of metanephric mesenchymal progenitors and mesenchymeto-epithelial differentiation in the kidney, as well as other specific developmental programs, have much left to reveal. Future studies of conditional/tissue or cell type-specific knockouts, genetic lineage tracing, and ChIP-seq analysis are essential for fully understanding how this complexity is regulated in different biological processes and disease states. 
